NUMERATOR GLP-1 INSIGHTS
GLP-1 Research Hub
Discover the latest GLP-1 insights and offerings from Numerator in our centralized GLP-1 research hub.
The latest GLP-1 research from Numerator
Article: Weighing the Consumer Impacts of GLP-1 Usage
GLP-1 medications—more commonly known by their brand names such as Ozempic and Wegovy— have the potential to reshape the eating and shopping habits of users. As these medications gain traction among consumers seeking weight-loss solutions…
Article: The Evolution of GLP-1 Users
Early research indicates GLP-1 households are pulling back on food and alcohol purchases more significantly than the average shopper. While these observed shifts provide important learnings for brands and retailers, businesses need more information to better anticipate where and whom these shifts will come from…
Numerator GLP-1 Data in the news
Press releases
11.09.2023
NUMERATOR LAUNCHES OMNICHANNEL GLP-1 DATASET TO UNDERSTAND CONSUMER BEHAVIOR
Households using GLP-1 for weight loss average 33 food & beverage shopping trips per…
11.30.2023
CONSUMERS USING GLP-1 MEDICATIONS SKEW YOUNGER AND HIGHER INCOME
42% of users planning to lose less than 15 pounds are Millennials or Gen Z…
12.05.2023
GLP-1 USERS FOCUSED ON WEIGHT LOSS ARE DECREASING FOOD PURCHASING
Buy rates are down -5% to -20% across key grocery departments for consumers using GLP-1…
Uncover valuable insights with Numerator's GLP-1 consumer data offerings.
The rise of GLP–1 drugs like Ozempic, Wegovy and others for weight loss are expected to lead to noticeable
shifts in consumer behavior for several categories. Uncover the long–term implications of this health–driven
consumer shift with Numerator’s GLP–1 People Groups and syndicated GLP–1 Survey.
GLP-1 People Groups
Numerator’s GLP-1 people groups come from a survey of over 100k panelists and identify GLP-1 users, use cases, time on drug and more.
Verified Shopping Behaviors
Track verified shifts in the shopping behaviors of GLP-1 users with purchase data across thousands of brands, categories, channels and retailers
Syndicated GLP-1 Study
Dive deeper into consumers’ long-term plans for GLP-1 usage, claimed lifestyle changes while on the drug, impact of lapsed usage and more.
Timely Updates
Numerator’s initial GLP-1 people groups were launched in October 2023 and will refresh quarterly in 2024 to reflect new and lapsed users.
Learn more about Numerator's GLP-1 offerings.
Interested in gaining access to Numerator’s GLP-1 People Groups or Syndicated Study? Reach out to our team today to start the conversation.